Opzelura 1.5% cream 60GM
Ended Awarded Last action
- Contract number
- SPE2DR26F95D6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,004
Award facts
- Contract value 100% obligated
- $10,003.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $10,003.72. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the supplier to furnish pharmaceuticals and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC serves as a flexible contracting vehicle supporting the DLA's medical supply chain operations, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards to optimize pharmaceutical distribution capabilities.
Quick answers
Who was awarded contract SPE2DR26F95D6?
SPE2DR26F95D6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26F95D6 worth?
The government has obligated $10,004 on SPE2DR26F95D6.
Is contract SPE2DR26F95D6 an order under another contract?
Yes. SPE2DR26F95D6 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F95D6 competed?
The extent of competition for SPE2DR26F95D6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award